×
Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in CASPR2-antibody disease
Ceronie B., strippel C., uy C., BENNETT D., HANDEL A., Irani S.
DOI
10.1002/ana.27177
Type
Journal article
Publisher
Wiley
Publication Date
2024-12-24T00:00:00+00:00